SCHEMBL6895355

SCHEMBL6895355

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H](O)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 5/20 0.56
▸ LMNA P02545 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ RAPGEF3 O95398 2/20 0.56
▸ GMNN O75496 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ RAPGEF4 Q8WZA2 1/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ RXFP1 Q9HBX9 2/20 0.55
▸ AHCY P23526 4/20 0.52
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ DOT1L Q8TEK3 1/20 0.48
▸ PDE4A P27815 1/20 0.48
▸ PDE4B Q07343 1/20 0.48
▸ PDE4C Q08493 1/20 0.48
▸ PDE4D Q08499 1/20 0.48
▸ PDE3B Q13370 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15293688 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL16271105 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL2233969 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL12222445 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL23813544 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL14946346 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL22983991 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL9964279 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL29674371 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL12352435 1.00 STING1 (0.56) STING1LMNAKMT2ARAPGEF3GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604409-B1 OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS INC (US) 2004-07-14 — — EP disclosed
EP-1418179-A2 Compositions and methods for detecting and modulating rna activity and gene expression ISIS PHARMACEUTICALS, INC. (US) 2004-05-12 — — EP disclosed
US-6262241-B1 ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES ISIS PHARMACEUTICALS, INC. 2001-07-17 — — US disclosed
Send feedback